Talquetamab Uses, Dosage, Side Effects and more
Talquetamab is under investigation in clinical trial NCT04634552 (A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma).
| Attribute | Details |
|---|---|
| Trade Name | Talquetamab |
| Generic | Talquetamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
